FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) —
Motus GI Holdings, Inc.
, (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year financial results on Tuesday, March 29, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
|
Conference Call and Webcast |
||
| Date and Time: |
Tuesday, March 29 th at 4:30 p.m. ET |
|
| Domestic: | 877-407-0792 | |
| International: | 201-689-8263 | |
| Passcode: | 13727501 | |
| Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1533147&tp_key=9ce5b7fd09 |
|
A replay of the webcast will be archived on the Motus GI website,
www.motusgi.com
, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit
www.motusgi.com
and connect with the Company on
Twitter
,
LinkedIn
and
Facebook
.
Investor Contact:
Troy Williams
LifeSci Advisors
(518) 221-0106
[email protected]
